Enabling you to identify and mitigate the intrinsic risk in your operations, supply chains and business processes.
Evaluating how your products and services meet and exceed quality, safety, sustainability and performance standards.
Validating the specifications, value and safety of your raw materials, products and assets.
Our inhalation drug development experts to exhibit at Respiratory Drug Delivery (RDD) 2018 Conference, Tucson, Arizona, April 22-26, 2018
During RDD 2018, Intertek's inhalation experts will be present to discuss aerosol drug delivery development topics including strategic approaches to OINDP development and novel in vitro testing methods such as the use of MDRS data as part of a weight-of-evidence approach in lieu of a traditional clinical endpoint study for generic nasal suspensions. Our team will also provide updates on the latest developments of our inhaled product development capabilities which includes for both small molecules and biologics.
Respiratory drug delivery development can be a challenging process yet there is a clear need to develop more effective orally inhaled and nasal drug products (OINDPs) to treat lung infection and lung disease. The lung can also present an effective delivery route to the rest of the body, potentially achieving a faster therapeutic effect and reducing the side effects that can be associated with other drug delivery routes.
Our integrated formulation and analytical teams carry out early stage pre-formulation support, solubility screening, drug-excipient compatibility, stability testing and device selection support to aid clients working to develop formulations targeting specific regions of the respiratory tract or nasal cavity. Comprehensive protein characterisation services services, aligned to monitoring a protein’s structure and potency throughout formulation and storage, can also be provided.
WEBINAR ON DEMAND: Formulation Strategies for Orally Inhaled and Nasal Drug Products
WHITE PAPER: The Fundamentals of Inhaled Product Testing
Learn More About RDD 2018
RDD 2018 offers attendees the unique opportunity to participate in one of the largest and most focused international conference of its kind, featuring in-depth presentations and discussion of pioneering respiratory drug delivery science in tandem with expanded opportunities for networking. Expert speakers will cover topics including new therapeutic opportunities and drug delivery technologies, novel in vitro and clinical testing methods, and new regulatory insight.
Venue: JW Marriott Starr Pass Resort and Spa, Tucson, Arizona
Date: April 22-26, 2018
Need help or have a question?